To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
Sponsor
Full profile: /officials/D000197
Source: Congress.gov · FEC
Cosponsors (4)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
4 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-09-02
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Education and WorkforceReferred To · 2026-09-02
- House Committee on Energy and CommerceReferred To · 2026-09-02
- House Committee on Ways and MeansReferred To · 2026-09-02
Plain-English Summary
Plain-English summary pending. Introduced on 2026-09-02. Check back soon — summaries are generated as bills progress through Congress.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR3491DeOndra Dixon INCLUDE Project Act of 2025Passed House · 2026-07-21
- HR9392Medicare Advantage Cost Transparency ActReferred to Committee · 2026-06-25
- HRES1285Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.Referred to Committee · 2026-05-14
- HR8432To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.Referred to Committee · 2026-04-22